
Study Protocol - Efficacy and Safety of Pegylated-Proline-Interferon Alpha 2b (Aop2014) in Maintaining Deep Molecular Remissions in Patients with Chronic Myeloid Leukemia (CML) who Discontinue ABL-Kinase Inhibitor Therapy Version 1
No description specified
SEEK ID: https://ldh.kks-marburg.imise.uni-leipzig.de/documents/5?version=1
Filename: ENDURE_CML_Study Protocol_V07F_2021-03-01.pdf
Format: PDF document
Size: 1.03 MB

Creator
Submitter
Activity
Views: 51 Downloads: 0
Created: 27th Nov 2024 at 12:44

This item has not yet been tagged.

None
Version History
Version 1 (earliest) Created 27th Nov 2024 at 12:44 by Gerrit zur Hausen
No revision comments